AstraZeneca divests rights to established hypertension medicines | CredoWeb

Articol

AstraZeneca divests rights to established hypertension medicines

AstraZeneca divests rights to established hypertension medicines

Farmacie Cardiologie

Hypertension AstraZeneca Inderal (propranolol) Tenormin (atenolol) angina hypertension medicines Tenoretic Zestril (lisinopril) Zestoretic

Partajați:

Comentarii